About 100 Mg Azacitidine Injection
100 Mg Azacitidine Injection Reserve is a masterful solution for treating Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML). This popular, decorated product features excellent USP/EP standard compliance, presented as a sterile, single-use vial containing 100 mg lyophilized powder. Administered subcutaneously or intravenously after reconstitution with sterile water, its application ensures effective outcomes. Available in distinguished clearance packaging, it must be used under medical supervision and is best reserved for specialist healthcare settings. Protect this exceptional treatment from light and refrigerate for optimal shelf life. Distributors, exporters, suppliers, and traders in India can rely on its consistent quality.
Recommended Application and Suitability
The 100 Mg Azacitidine Injection is well-suited for healthcare facilities specializing in oncology and hematology. The decorated formula is administered subcutaneously or intravenously, following precise reconstitution with sterile water. Application is reserved for professional use under strict medical supervision, ensuring patient safety. Its white to off-white lyophilized powder format allows masterful dosing, supported by clear dilution instructions. This excellent product is ideal for treating patients diagnosed with MDS, CMML, or AML.
Export and Supply Estimates
100 Mg Azacitidine Injection is an export favorite, with the main markets including Asia, Africa, and the Middle East. Suppliers estimate optimal supply ability to meet both domestic and international demands, guaranteeing excellent value at the lowest price expenditure. Distribution in India is supported by masterful logistics, ensuring rapid clearance of orders and reliable access for local medical centers. Its popularity among traders stems from consistent quality and affordability.
FAQ's of 100 Mg Azacitidine Injection:
Q: How is 100 Mg Azacitidine Injection administered to patients?
A: The injection is given either subcutaneously or intravenously after reconstituting the lyophilized powder with sterile water for injection, under the supervision of a healthcare professional.
Q: What is the primary indication for using this product?
A: 100 Mg Azacitidine Injection is primarily indicated for the treatment of Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), and Acute Myeloid Leukemia (AML).
Q: When should the reconstituted injection be used?
A: Use the injection immediately after reconstitution, or within the time frame specified on the product label for maximum efficacy and safety.
Q: Where should 100 Mg Azacitidine Injection be stored?
A: Store the product in a refrigerator at 2C to 8C and protect it from light to preserve its strength and effectiveness throughout the 24-month shelf life.
Q: What precautions should be taken during administration?
A: 100 Mg Azacitidine Injection should only be administered under medical supervision. It is contraindicated in patients with hypersensitivity to Azacitidine or its excipients, and monitoring for side effects is essential.
Q: What are the possible side effects of this injection?
A: Common side effects may include nausea, vomiting, anemia, neutropenia, and thrombocytopenia. Consult your healthcare provider for more information and monitoring during treatment.